137 related articles for article (PubMed ID: 1169108)
1. Stem-cell survival and tumor control in the Lewis lung carcinoma.
Steel GG; Adams K
Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
[TBL] [Abstract][Full Text] [Related]
2. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
3. Size dependence of the response of Lewis lung tumors to BCNU.
Steel GG; Adams K; Stanley J
Cancer Treat Rep; 1976 Dec; 60(12):1743-8. PubMed ID: 1026332
[TBL] [Abstract][Full Text] [Related]
4. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
[TBL] [Abstract][Full Text] [Related]
5. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary metastases of the lewis lung tumor-cell kinetics and response to cyclophosphamide at different sizes.
Hill RP; Stanley JA
Cancer Treat Rep; 1977; 61(1):29-36. PubMed ID: 861961
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents.
Holden SA; Lan Y; Pardo AM; Wesolowski JS; Gillies SD
Clin Cancer Res; 2001 Sep; 7(9):2862-9. PubMed ID: 11555604
[TBL] [Abstract][Full Text] [Related]
8. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
Ono K; Shrieve DC
J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
[TBL] [Abstract][Full Text] [Related]
9. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
11. Survival of mice with metastatic osteosarcoma treated by cyclophosphamide or radiotherapy.
Shaeffer J; El-Mahdi AM; Constable WC
Cancer Res; 1975 Dec; 35(12):3596-8. PubMed ID: 1059504
[TBL] [Abstract][Full Text] [Related]
12. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents.
Teicher BA; Holden SA; Ara G; Northey D
Anticancer Res; 1993; 13(6A):2101-6. PubMed ID: 7507654
[TBL] [Abstract][Full Text] [Related]
13. Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.
Sacchi A; Calabresi F; Greco C; Zupi G
Invasion Metastasis; 1981; 1(4):227-38. PubMed ID: 6203864
[TBL] [Abstract][Full Text] [Related]
14. Methods of immunosuppression for study of growth and lung colony formation by human tumor cells in mice.
Kovnat A; Khoo K; Selby P; Tannock I
Cancer Res; 1986 Apr; 46(4 Pt 1):1617-22. PubMed ID: 3512076
[TBL] [Abstract][Full Text] [Related]
15. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
16. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
Stephens TC; Peacock JH
Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide chemotherapy of intrapulmonarily implanted Lewis lung carcinoma.
Ho W; Furst A
Proc West Pharmacol Soc; 1978; 21():397-400. PubMed ID: 693524
[No Abstract] [Full Text] [Related]
18. Lewis lung carcinoma in mice as an experimental therapy model. I. The growth kinetics and the effect of tumor on host.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):363-72. PubMed ID: 7184487
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
Phelan ET; Vietti TJ; Valeriote FA; Coulter D
Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]